1832 Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,010,119
Closed -$9.5M – 864
2023
Q1
$9.5M Buy
+1,010,119
New +$11.9M 0.01% 356
2022
Q4
– Sell
-1,415,615
Closed -$17.6M – 918
2022
Q3
$17.6M Buy
1,415,615
+849,700
+150% +$14.9M 0.03% 289
2022
Q2
$11.1M Sell
565,915
-298,215
-35% -$7.06M 0.02% 352
2022
Q1
$22.2M Sell
864,130
-620,520
-42% -$16.5M 0.03% 297
2021
Q4
$43M Buy
1,484,650
+150,462
+11% +$4.68M 0.08% 189
2021
Q3
$43.3M Buy
1,334,188
+1,123,788
+534% +$37.7M 0.08% 184
2021
Q2
$7.42M Sell
210,400
-126,500
-38% -$4.17M 0.01% 353
2021
Q1
$9.75M Sell
336,900
-194,992
-37% -$6M 0.02% 293
2020
Q4
$16.1M Buy
+531,892
New +$16.2M 0.04% 253

Other funds holding ELAN

1832 Asset Management's ELAN Position: Q2 2023 in Review

1832 Asset Management sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 1,010,119 shares — an estimated $9.5M sold.

1832 Asset Management first reported a position in ELAN in Q4 2020 and held it in 9 quarters. The position peaked at $43.3M in Q3 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • 1832 Asset Management reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • 1832 Asset Management sold 1,010,119 Elanco Animal Health shares in Q2 2023, an estimated $9.5M.
  • 1832 Asset Management first reported a position in Elanco Animal Health in Q4 2020 and held it in 9 quarters.
  • 1832 Asset Management's Elanco Animal Health position peaked at $43.3M in Q3 2021.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on 1832 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.